Quantum-Si (QSI) Projected to Post Quarterly Earnings on Tuesday

Quantum-Si (NASDAQ:QSI) will likely be announcing its Q4 2025 results after the market closes on Tuesday, March 3rd. Analysts expect the company to announce earnings of ($0.14) per share and revenue of $0.7620 million for the quarter. Interested persons can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Tuesday, March 3, 2026 at 4:30 PM ET.

Quantum-Si Stock Performance

Quantum-Si stock opened at $0.96 on Friday. Quantum-Si has a fifty-two week low of $0.89 and a fifty-two week high of $3.10. The firm’s fifty day moving average price is $1.13 and its 200-day moving average price is $1.38. The stock has a market cap of $206.09 million, a P/E ratio of -1.43 and a beta of 2.98.

Insider Activity

In other Quantum-Si news, insider John S. Vieceli sold 21,927 shares of Quantum-Si stock in a transaction dated Monday, December 22nd. The stock was sold at an average price of $1.28, for a total transaction of $28,066.56. Following the completion of the transaction, the insider owned 800,973 shares in the company, valued at approximately $1,025,245.44. This trade represents a 2.66% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Jeffrey Alan Hawkins sold 23,707 shares of the firm’s stock in a transaction dated Monday, December 22nd. The shares were sold at an average price of $1.28, for a total value of $30,344.96. Following the sale, the chief executive officer owned 2,578,018 shares in the company, valued at $3,299,863.04. This trade represents a 0.91% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 54,261 shares of company stock worth $69,454 over the last ninety days. 30.04% of the stock is owned by insiders.

Institutional Trading of Quantum-Si

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Prudential Financial Inc. acquired a new stake in Quantum-Si in the second quarter valued at $25,000. Cerity Partners LLC purchased a new position in Quantum-Si during the second quarter worth $29,000. BNP Paribas Financial Markets raised its stake in Quantum-Si by 101.3% during the third quarter. BNP Paribas Financial Markets now owns 30,464 shares of the company’s stock worth $43,000 after purchasing an additional 15,331 shares during the period. Dimensional Fund Advisors LP purchased a new stake in Quantum-Si during the fourth quarter worth approximately $34,000. Finally, State Board of Administration of Florida Retirement System acquired a new position in shares of Quantum-Si during the fourth quarter worth $45,000. 39.90% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Canaccord Genuity Group decreased their price target on shares of Quantum-Si from $2.00 to $1.50 and set a “hold” rating for the company in a research note on Monday, December 22nd. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Quantum-Si in a research note on Monday, December 29th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Quantum-Si currently has an average rating of “Hold” and a consensus price target of $3.55.

Quantum-Si Company Profile

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.